LeCaer, H., Barlesi, F., Corre, R., Jullian, H., Bota, S., Falchero, L., . . . Chouaid, C. (2011). A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study). Nature Publishing Group.

LeCaer, H., et al. A Multicentre Phase II Randomised Trial of Weekly Docetaxel/gemcitabine Followed By Erlotinib On Progression, Vs the Reverse Sequence, in Elderly Patients With Advanced Non Small-cell Lung Cancer Selected With a Comprehensive Geriatric Assessment (the GFPC 0504 Study). Nature Publishing Group, 2011.

LeCaer, H., et al. A Multicentre Phase II Randomised Trial of Weekly Docetaxel/gemcitabine Followed By Erlotinib On Progression, Vs the Reverse Sequence, in Elderly Patients With Advanced Non Small-cell Lung Cancer Selected With a Comprehensive Geriatric Assessment (the GFPC 0504 Study). Nature Publishing Group, 2011.